Your browser doesn't support javascript.
loading
Case Report: Erysipeloid Cutaneous Leishmaniasis Treated with Oral Miltefosine.
Parajuli, Niraj; Adhikary, Sabeena; Karki, Anupama; Tiwari, Sumida.
Afiliación
  • Parajuli N; 1Department of Dermatology and Venereology, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
  • Adhikary S; 1Department of Dermatology and Venereology, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
  • Karki A; 1Department of Dermatology and Venereology, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
  • Tiwari S; 2Department of Pathology, National Academy of Medical Sciences, Bir Hospital, Kathmandu, Nepal.
Am J Trop Med Hyg ; 104(2): 643-645, 2020 11 23.
Article en En | MEDLINE | ID: mdl-33236713
ABSTRACT
Cutaneous leishmaniasis (CL) can present with various skin lesions ranging from a single ulcer to diffuse multiple nodules. Here, we present a case of a 67-year-old man with a large erythematous well-defined indurated plaque over the left face for a duration of 4 months. A slit skin smear was performed, and it was stained with Giemsa stain which showed multiple amastigotes confirming the diagnosis of CL. Oral miltefosine was started at a dose of 150 mg/day but had to be stopped after 20 days as the patient developed diarrhea, bipedal edema, and renal impairment. This case emphasizes an uncommon variant of CL and the role of systemic treatment with oral miltefosine and its associated adverse effects.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosforilcolina / Leishmaniasis Cutánea / Antiprotozoarios Límite: Aged / Humans / Male Idioma: En Revista: Am J Trop Med Hyg Año: 2020 Tipo del documento: Article País de afiliación: Nepal

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fosforilcolina / Leishmaniasis Cutánea / Antiprotozoarios Límite: Aged / Humans / Male Idioma: En Revista: Am J Trop Med Hyg Año: 2020 Tipo del documento: Article País de afiliación: Nepal